J I Bell

2.8k total citations
25 papers, 2.1k citations indexed

About

J I Bell is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, J I Bell has authored 25 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in J I Bell's work include T-cell and B-cell Immunology (8 papers), Diabetes and associated disorders (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). J I Bell is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Diabetes and associated disorders (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). J I Bell collaborates with scholars based in United Kingdom, United States and India. J I Bell's co-authors include Gavin Screaton, David G. Jackson, M.V. Bell, William Rosenberg, D P Jewell, Jack Satsangi, Andrew J. McMichael, Cécile Julier, Michael Bunce and J. Mark Farrant and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

J I Bell

24 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J I Bell United Kingdom	18	954	681	597	316	212	25	2.1k
M B Pepys United Kingdom	19	945 1.0×	625 0.9×	157 0.3×	180 0.6×	165 0.8×	35	1.9k
Adrian Kelly United Kingdom	7	1.3k 1.3×	653 1.0×	313 0.5×	168 0.5×	80 0.4×	9	1.9k
Nobuaki Kawamura Japan	19	1.2k 1.2×	363 0.5×	450 0.8×	327 1.0×	100 0.5×	51	1.9k
Eric R. Fedyk United States	19	737 0.8×	437 0.6×	751 1.3×	542 1.7×	236 1.1×	39	1.9k
Christine M. Seroogy United States	23	1.4k 1.4×	746 1.1×	392 0.7×	297 0.9×	121 0.6×	77	2.3k
Samuel J. Pirruccello United States	26	873 0.9×	665 1.0×	313 0.5×	325 1.0×	137 0.6×	79	2.4k
Anke Peters Germany	12	1.3k 1.3×	1.2k 1.7×	157 0.3×	317 1.0×	136 0.6×	23	2.5k
Massimo Fiorilli Italy	28	1.1k 1.2×	468 0.7×	270 0.5×	584 1.8×	171 0.8×	118	2.5k
John Simard United States	17	1.9k 2.0×	684 1.0×	183 0.3×	229 0.7×	232 1.1×	24	3.0k
R J Noelle United States	13	2.3k 2.4×	363 0.5×	250 0.4×	210 0.7×	124 0.6×	14	2.8k

Countries citing papers authored by J I Bell

Since Specialization

Citations

This map shows the geographic impact of J I Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J I Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J I Bell more than expected).

Fields of papers citing papers by J I Bell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J I Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J I Bell. The network helps show where J I Bell may publish in the future.

Co-authorship network of co-authors of J I Bell

This figure shows the co-authorship network connecting the top 25 collaborators of J I Bell. A scholar is included among the top collaborators of J I Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J I Bell. J I Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bell, J I. (2007). The Molecular Genetics of HLA‐Related Disorders. Novartis Foundation symposium. 130. 197–214.

Bell, J I. (2003). Resuscitating clinical research in the United Kingdom. BMJ. 327(7422). 1041–1043. 56 indexed citations

Xu, Xiaotian, et al.. (1998). Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL.. PubMed. 160(1). 3–6. 122 indexed citations

Satsangi, Jack, D P Jewell, & J I Bell. (1997). The genetics of inflammatory bowel disease.. Gut. 40(5). 572–574. 99 indexed citations

Farrant, J. Mark, et al.. (1996). Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. The Lancet. 347(9010). 1212–1217. 268 indexed citations

Screaton, Gavin, Javier F. Cáceres, Akila Mayeda, et al.. (1995). Identification and characterization of three members of the human SR family of pre-mRNA splicing factors.. The EMBO Journal. 14(17). 4336–4349. 254 indexed citations

Julier, Cécile, Anneke Lucassen, Marc Délepine, et al.. (1994). Multiple DNA variant association analysis: application to the insulin gene region in type I diabetes.. PubMed. 55(6). 1247–54. 44 indexed citations

Satsangi, Jack, D P Jewell, William Rosenberg, & J I Bell. (1994). Genetics of inflammatory bowel disease.. Gut. 35(5). 696–700. 110 indexed citations

Patel, P., Y. M. Dennis Lo, J I Bell, & James S. Wainscoat. (1993). Rapid HLA typing by multiplex amplification refractory mutation system.. Journal of Clinical Pathology. 46(12). 1105–1108. 2 indexed citations

10.

Lo, Y. M. Dennis, P. Patel, Wajahat Z. Mehal, et al.. (1992). Analysis of complex genetic systems by ARMS-SSCP: application to HLA genotyping. Nucleic Acids Research. 20(5). 1005–1009. 33 indexed citations

11.

Pile, K, Nicholas Willcox, J I Bell, & B P Wordsworth. (1992). A novel HLA‐DR4 allele (DRB1*O414) in a patient with myasthenia gravis. Tissue Antigens. 40(5). 264–266. 16 indexed citations

12.

Wordsworth, B. P., et al.. (1991). LIMITED HETEROGENEITY OF THE HLA CLASS II CONTRIBUTION TO SUSCEPTIBILITY TO RHEUMATOID ARTHRITIS IS SUGGESTED BY POSITIVE ASSOCIATIONS WITH HLA—DR4, DR1 AND DRwlO. Lara D. Veeken. 30(3). 178–180. 33 indexed citations

13.

Ratcliffe, Peter J., Richard W. Jones, R E Phillips, Lynn G. Nicholls, & J I Bell. (1990). Oxygen-dependent modulation of erythropoietin mRNA levels in isolated rat kidneys studied by RNase protection.. The Journal of Experimental Medicine. 172(2). 657–660. 69 indexed citations

14.

Bell, J I. (1989). The major histocompatibility complex and disease. Current Opinion in Immunology. 2(1). 114–116. 3 indexed citations

15.

Bangham, Charles R. M., Susan Daenke, R E Phillips, J.K. Cruickshank, & J I Bell. (1988). Enzymatic amplification of exogenous and endogenous retroviral sequences from DNA of patients with tropical spastic paraparesis.. The EMBO Journal. 7(13). 4179–4184. 52 indexed citations

16.

Bell, J I, et al.. (1987). HLA‐DR restriction‐fragment‐length polymorphisms in narcolepsy. Journal of Neuroscience Research. 18(1). 239–244. 9 indexed citations

17.

Bell, J I, et al.. (1987). Allelic variation in the DR subregion of the human major histocompatibility complex.. Proceedings of the National Academy of Sciences. 84(17). 6234–6238. 193 indexed citations

18.

Wainscoat, J. S., et al.. (1987). Allele-specific DNA identity patterns. Human Genetics. 75(4). 384–387. 12 indexed citations

19.

Bell, J I, et al.. (1986). HLA-DQ BETA-CHAIN POLYMORPHISM LINKED TO MYASTHENIA GRAVIS. The Lancet. 327(8489). 1058–1060. 108 indexed citations

20.

Bell, J I, Pila Estess, Tom St. John, et al.. (1985). DNA sequence and characterization of human class II major histocompatibility complex beta chains from the DR1 haplotype.. Proceedings of the National Academy of Sciences. 82(10). 3405–3409. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact